Roche Innovation Center Copenhagen competitive analysis

Explore patent oppositions filed by Roche Innovation Center Copenhagen against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Jun 25, 2026
Patent NumberTitleApplicantOpposition Date
Compositions And Methods For Modulating Gene ExpressionRANA THERAPEUTICSAug 2, 2019
Modulation Of Rna By Repeat TargetingIONIS PHARMACEUTICALSAug 13, 2018
Hbv Antisense InhibitorsGLAXO GROUPJul 10, 2018
Polycomb-Associated Non-Coding RnasTHE GENERAL HOSPITALFeb 13, 2018
Linkage Modified Gapped Oligomeric Compounds And Uses ThereofIONIS PHARMACEUTICALSFeb 2, 2018

Explore Roche Innovation Center Copenhagen's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 25, 2026
Patent NumberPublication DateTitleTotal Oppositions
Feb 12, 2020Antisense Design1

Latest PTAB cases involving Roche Innovation Center Copenhagen

Discover the latest PTAB cases involving Roche Innovation Center Copenhagen, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Roche Innovation Center Copenhagen with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Jun 25, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ROCHE393134
IONIS PHARMACEUTICALS222 - -
ISIS PHARMACEUTICALS - 13 - -
THE GENERAL HOSPITAL - 30 - 2